726 
High Morbidity and Mortality in a Cohort of Perinatally HIV-1-infected Children in Baja California, Mexico
Rolando Viani*1, M Araneta1, P Hubbard1, G Lopez2, E Chacon2, and S Spector1
1Univ of California, San Diego, US and 2Tijuana Gen Hosp, Mexico
Background: We recently documented a higher-than-suspected
prevalence of HIV infection among pregnant women and a high mother-to-child HIV
transmission rate at the Tijuana General
Hospital in Baja California, Mexico. This study evaluated HIV-related
disease progression in children identified through this program.
Methods: Children diagnosed with HIV infection and
followed at the Pediatric HIV clinic at Tijuana General Hospital
between 1998 and 2005 were observed longitudinally for CD4 cell percentage,
plasma HIV RNA log10, ART, morbidity, and death. Median survival was
calculated by the Kaplan-Meier method.
Results: A total of 65 children were followed during
the study period: 55% were boys; mean
age at HIV diagnosis was 2.6 years (±3.54), 55% were diagnosed before their second
birthday. We diagnosed 41 cases (63%) with HIV between 2002 and 2005: 32 cases (49%) were CDC classification group C
at the time of HIV diagnosis and 42 cases (62%) had ≥1 admission to the
hospital prior to HIV diagnosis. Pneumonia was the most common morbidity (37%)
at or prior to HIV diagnosis, followed by failure to thrive (20%) and Pneumocystis pneumonia (PCP; 12%). Mean
CD4 percentage was 19%, 23%, 23%, and 27% for the years 1998-1999, 2000-2001,
2002-2003, and 2004-2005, respectively (p
= 0.3). HIV RNA log10 did not change over time and was 5.4, 5.2,
5.4, and 5.4 for the years 1998-1999, 2000-2001, 2002-2003, and 2004-2005,
respectively (p = 0.9). Triple drug
combination ART was used in 50% of patients during 1998-1999 and during 2000
and increased to 82% for the period between 2001 and 2005. Overall mortality
was 29% (19 of 65) with pneumonia as the most common cause of death (58% of all
deaths) followed by PCP, tuberculosis, and meningitis with 10% each. When
stratified by year of diagnosis, no temporal trends were observed in morbidity
or CDC clinical classification at the time of HIV diagnosis. The mortality rate
decreased significantly over time, from 18.8% in 2000-2001, to 14.3% in 2002-2003
to 5.6% in 2004-2005 (p = 0.0002).
Mean age at death was 3 years (±4.08). Kaplan Meier survival analysis showed
that the median survival was 6.85 years; 75% were alive by their second birthday
and 58% survived by their fifth birthday.
Conclusions: These findings indicate a high morbidity at
the time of HIV diagnosis and a declining mortality in this cohort of
perinatally HIV-infected children in Baja California, Mexico.
|